No Reason to Get Excited about Athenahealth (ATHN), Thinks Oppenheimer

Article Related Press Releases (1) Related Articles (1) Stock Quotes (1) Comments (0)

On Thursday Athenahealth (NASDAQ: ATHN) reported reported Q4 results, with EPS topping estimates by a penny on revenue of $116.3 million, just shy of consensus estimates of $116.97 million.

Commenting on the news, analyst Bret Jones of Oppenheimer said, "We believe the higher growth rate in collections versus revenue is indicative of pricing pressure. Discounting on enterprise deals needs to be monitored, we think, given the increased dependence on enterprise wins. However, with essentially in-line doc adds and a strong pipeline for 2013, we only expect the shares to be modestly off."

Unsurprisingly, Oppenheimer has a Perform rating on athenahealth.

For an analyst ratings summary and ratings history on athenahealth (NASDAQ: ATHN) click here. For more ratings news on athenahealth click here.

Shares of athenahealth closed at $88.37 yesterday, with a 52 week range of $56.33-$97.37.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Deutsche Bank Downgrades TRW Automotive Holdings (TRW) to Hold
• Wells Fargo Downgrades Brinker Int'l (EAT) to Market Perform

Create E-mail Alert Related Categories

Analyst Comments

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?